Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma?

被引：0
|
作者：
Andrew Jacobs
机构：
[1] Chief of Cancer Care Services and Medical Director of Clinical Research at the Benaroya Research Institute at Virginia Mason Medical Center,
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：424 / 425
页数：1
相关论文
共 50 条
  • [1] Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma?
    Jacobs, Andrew
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (08): : 424 - 425
  • [2] Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: Randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group
    Lutz, MP
    Van Cutsem, E
    Wagener, T
    Van Laethem, JL
    Vanhoefer, U
    Wils, JA
    Gamelin, E
    Koehne, CH
    Arnaud, JP
    Mitry, E
    Husseini, F
    Reichardt, P
    El-Serafi, M
    Etienne, PL
    Lingenfelser, T
    Praet, M
    Genicot, B
    Debois, M
    Nordlinger, B
    Ducreux, MP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9250 - 9256
  • [3] Gemcitabine Versus Docetaxel Plus Cisplatin as Induction Chemotherapy in Nasopharyngeal Carcinoma
    Chen, Qian
    Li, Shan
    LARYNGOSCOPE, 2022, 132 (12): : 2379 - 2387
  • [4] Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma
    Sun, Xue-Song
    Wang, Xiao-Hao
    Liu, Sai-Lan
    Luo, Dong-Hua
    Sun, Rui
    Liu, Li-Ting
    Guo, Shan-Shan
    Chen, Qiu-Yan
    Tang, Lin-Quan
    Mai, Hai-Qiang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [5] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zhen Zeng
    Ruo-Nan Yan
    Li Tu
    Yu-Yi Wang
    Pei-Ran Chen
    Feng Luo
    Lei Liu
    Scientific Reports, 8
  • [6] Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
    Zeng, Zhen
    Yan, Ruo-Nan
    Tu, Li
    Wang, Yu-Yi
    Chen, Pei-Ran
    Luo, Feng
    Liu, Lei
    SCIENTIFIC REPORTS, 2018, 8
  • [7] Nedaplatin plus Docetaxel versus Cisplatin plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung
    Lu, S.
    Chen, Z.
    Hu, C.
    Xin-Ling, R.
    Chen, Y.
    Song, Y.
    Qiong, Z.
    Fan, Y.
    Gang, W.
    Zhi-Yong, M.
    Fang, J.
    Qi-Tao, Y.
    Liu, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1807 - S1808
  • [8] Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine
    Tomova, A.
    Brodowicz, T.
    Tzekova, V.
    Timcheva, C.
    Wiltschke, C.
    Gerges, D. A.
    Pawlega, J.
    Spanik, S.
    Inbar, M. J.
    Zielinski, C. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Comparison of concurrent chemoradiation therapy plus induction chemotherapy with cisplatin, fluorouracil and docetaxel versus gemcitabine and cisplatin in advanced nasopharyngeal carcinoma
    Zeng, Z.
    Yan, R.
    Tu, L.
    Wang, Y.
    Chen, P.
    Luo, F.
    Liu, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Activity and tolerability of gemcitabine plus cisplatin in advanced metastatic pancreatic carcinoma
    Heinemann, V
    Wilke, H
    Possinger, K
    Mergenthaler, K
    Clemens, M
    Konig, HJ
    Illiger, HJ
    Lackhoff, A
    Blatter, J
    Schallhorn, A
    Fink, U
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1240 - 1240
12345